Researchers at Arizona State University have developed a breakthrough diagnostic tool that could transform how quickly and reliably we detect illnesses like COVID-19, Ebola, AIDS or Lyme disease. The test uses just a single drop of blood, costs a couple of dollars and delivers results in only 15 minutes.

Researchers at a FAPESP-supported research center have managed to reduce Candida albicans’ resistance to fungicides by incorporating photodynamic inactivation techniques into the treatment. The results of the study indicate that the technology can be used in both human healthcare and the prevention of food contamination.  

The Phase 3, multicenter, randomized, interventional, controlled trial will assess the safety and efficacy of the Apreo BREATHE Airway Scaffold, an implantable, tissue-sparing device that was granted U.S. Food and Drug Administration (FDA) Breakthrough Device Designation in May 2024. During the minimally invasive procedure, up to six of the self-expanding scaffolds (three per lung) are placed using bronchoscopy and fluoroscopy for those randomized to the treatment group. This design allows trapped air to move back and forth, relaxing the airways and enabling trapped air to escape.